Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111K Buy
85,400
+3,200
+4% +$4.41K ﹤0.01% 12424
2026
Q1
$106K Sell
82,200
-8,600
-9% -$14.2K ﹤0.01% 12307
2025
Q4
$201K Buy
+90,800
New +$171K ﹤0.01% 10873
2025
Q2
Sell
-10,600
Closed -$71.3K 13275
2025
Q1
$71.3K Sell
10,600
-300
-3% -$2.12K ﹤0.01% 11733
2024
Q4
$74K Buy
10,900
+100
+0.9% +$658 ﹤0.01% 11513
2024
Q3
$89.5K Buy
+10,800
New +$78.1K ﹤0.01% 11115
2023
Q1
Sell
-36,000
Closed -$303K 13108
2022
Q4
$303K Buy
36,000
+26,000
+260% +$247K ﹤0.01% 9068
2022
Q3
$167K Buy
+10,000
New +$184K ﹤0.01% 11098
2022
Q2
Sell
-194,000
Closed -$4.81M 13512
2022
Q1
$4.81M Buy
+194,000
New +$5.01M ﹤0.01% 3697

Other funds holding LUNG

Jeff Yass's LUNG Position: Q2 2026 in Review

Jeff Yass reduced its Pulmonx (LUNG) stake by 28% in Q2 2026, selling an estimated $34K and leaving 64,373 shares worth $83.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12610.

Jeff Yass first reported a position in LUNG in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.51M in Q1 2022. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Jeff Yass held 64,373 shares of Pulmonx worth $83.7K as of Q2 2026.
  • Jeff Yass sold 24,696 Pulmonx shares in Q2 2026, an estimated $34K.
  • Pulmonx made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12610 holding.
  • Jeff Yass first reported a position in Pulmonx in Q1 2022 and has held it in 18 quarters since.
  • Jeff Yass's Pulmonx position peaked at $4.51M in Q1 2022.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.